A third dose of a COVID-19 vaccine is safe and effective to boost protection in organ transplant recipients
Organ transplant recipients often receive immunosuppressant drugs to avoid transplant rejection, but these compounds affect their ability to mount immunity effectively when vaccinated.
Recovery after prolonged Intensive Care Unit treatment for COVID-19 patients
A recent commentary in Lancet Respiratory Medicine by CITF-funded researcher Dr. Margaret Herridge and colleagues highlights the record volume of COVID-19 patients treated for prolonged periods in Intensive Care Units (ICUs) around the world.
Challenges and uncertainties around VOCs in children with solid organ transplants
In this short perspective in Pediatric Transplantation, CITF-funded researcher Dr. Upton Allen and colleagues present the latest evidence regarding the impact of variants of concern (VOCs) in children with solid organ transplants.
Social inequalities at the center of COVID-19 hotspots in Canada
COVID-19 has not affected all Canadian communities equally. A growing body of literature is highlighting the inequalities in communities with high rates of COVID-19.
Study of blood donors shows many asymptomatic infections during the first COVID-19 wave in Quebec
A study led by Héma-Québec, the provincial blood collection agency, supported by the CITF and featuring CITF-funded researcher, Dr. Andrés Finzi, showed that 2.23% of blood donors were seropositive for SARS-CoV-2 between May 25 and July 9, 2020: about four times higher than the number of PCR-confirmed COVID-19 cases during the same period.
Sewage can reveal the true spread of SARS-CoV-2 in a community
Wastewater surveillance for COVID-19 involves testing sewage for SARS-CoV-2 RNA, which if present, would suggest some level of infection in the source population. In a recent preprint, therefore not yet peer-reviewed, researchers present a computational model to better understand the dynamics between transmission of the virus in a community and its concentration in the wastewater.
What is needed to achieve herd immunity against SARS-Cov-2?
In this brief communication by CITF-funded researcher Dr Shelly Bolotin and colleagues, five key elements to achieve and maintain herd immunity Herd immunity is reached when a large proportion of the population is immune to a specific disease, reducing the spread of the disease from person to person. are presented.
From lessons learned to action: towards a pan-Canadian immunization system
As we navigate the ongoing pandemic, the effectiveness of Canada’s pandemic response is being evaluated. The auditor-general’s report, released in March 2021, outlined challenges, missteps, and lessons learned.
Vaccine hesitancy is low among public school teachers in British Columbia
In British Columbia (BC), where schools were open for the 2020-21 academic year, teachers were surveyed to better understand their perceptions around vaccination and measure their willingness to accept a COVID-19 vaccine.